D-0391-2026 Class III Ongoing

Recalled by Annora Pharma Private Limited — Hyderabad, N/A

FDA drug recall D-0391-2026 was initiated by Annora Pharma Private Limited on Feb 3, 2026 and is designated Class III. Reason for recall: Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg The recall status is ongoing. Affected quantity: 770 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 25, 2026
Initiation Date
Feb 3, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
770 bottles

Product description

Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Annora Pharma Pvt. LTd., Sengareddy - 502313, Telengana, India, NDC 72603-479-01.

Reason for recall

Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg

Distribution pattern

TN

Code information

Lot #: A252487, Exp 05/31/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0391-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0391-2026. Report a data issue: hello@regdatalab.com.